このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Paysign 将来の成長

Future 基準チェック /16

Paysignの収益は年間32%で減少すると予測されていますが、年間収益は年間14.3%で増加すると予想されています。EPS は年間33.9%で減少すると予想されています。

主要情報

-32.0%

収益成長率

-33.9%

EPS成長率

Diversified Financial 収益成長	-0.2%
収益成長率	14.3%
将来の株主資本利益率	n/a
アナリストカバレッジ	Low
最終更新日	04 Jun 2024

今後の成長に関する最新情報

Recent updates

Paysign: Expect Rapid Growth In Its Pharma Business

Jun 30

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Apr 26

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Aug 13

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

Jun 14

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

May 16

PaySign: A 'Backdoor' $2 Stagflation Play

Mar 29

Paysign: My Top Rebound Pick For 2022

Dec 28

Paysign: The Plasma Toll Booth

Sep 23

PaySign's Post-Pandemic Payoff

Sep 07

Why PaySign Is A Very Good Company

Dec 28

PaySign: Long-Term Story Still Intact

Dec 21

Paysign reports Q3 results

Nov 17

業績と収益の成長予測

NasdaqCM:PAYS - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2025	65	4	N/A	N/A	4
12/31/2024	57	3	N/A	N/A	4
3/31/2024	50	7	25	33	N/A
12/31/2023	47	6	21	28	N/A
9/30/2023	44	2	-8	-1	N/A
6/30/2023	42	1	4	9	N/A
3/31/2023	40	1	18	23	N/A
12/31/2022	38	1	21	25	N/A
9/30/2022	36	0	27	30	N/A
6/30/2022	33	-1	11	14	N/A
3/31/2022	31	-1	8	10	N/A
12/31/2021	29	-3	13	15	N/A
9/30/2021	28	-7	14	17	N/A
6/30/2021	20	-13	25	27	N/A
3/31/2021	20	-12	10	13	N/A
12/31/2020	24	-9	10	14	N/A
9/30/2020	27	-3	14	18	N/A
6/30/2020	36	6	-2	3	N/A
3/31/2020	38	8	3	7	N/A
12/31/2019	35	7	13	17	N/A
9/30/2019	32	6	16	18	N/A
6/30/2019	29	4	27	29	N/A
3/31/2019	26	3	33	34	N/A
12/31/2018	23	3	14	16	N/A
9/30/2018	21	2	10	12	N/A
6/30/2018	19	2	8	10	N/A
3/31/2018	17	2	6	7	N/A
12/31/2017	15	2	N/A	7	N/A
9/30/2017	14	2	N/A	6	N/A
6/30/2017	12	2	N/A	3	N/A
3/31/2017	11	2	N/A	5	N/A
12/31/2016	10	1	N/A	4	N/A
9/30/2016	10	1	N/A	1	N/A
6/30/2016	9	-2	N/A	3	N/A
3/31/2016	9	-2	N/A	0	N/A
12/31/2015	8	-2	N/A	-1	N/A
9/30/2015	11	0	N/A	3	N/A
6/30/2015	11	3	N/A	3	N/A
3/31/2015	9	2	N/A	2	N/A
12/31/2014	10	3	N/A	3	N/A
9/30/2014	7	0	N/A	1	N/A
6/30/2014	7	0	N/A	0	N/A
3/31/2014	7	0	N/A	0	N/A
12/31/2013	6	1	N/A	-1	N/A
9/30/2013	6	0	N/A	0	N/A

アナリストによる今後の成長予測

収入対貯蓄率: PAYSの収益は今後 3 年間で減少すると予測されています (年間-32% )。

収益対市場: PAYSの収益は今後 3 年間で減少すると予測されています (年間-32% )。

高成長収益: PAYSの収益は今後 3 年間で減少すると予測されています。

収益対市場: PAYSの収益 ( 14.3% ) US市場 ( 8.7% ) よりも速いペースで成長すると予測されています。

高い収益成長: PAYSの収益 ( 14.3% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: PAYSの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Paysign 将来の成長

Future 基準チェック /16

主要情報

今後の成長に関する最新情報

Consensus EPS estimates increase by 33%

Price target increased by 8.9% to US$6.13

Consensus EPS estimates fall by 30%, revenue upgraded

Price target increased by 14% to US$5.25

Consensus EPS estimates increase by 25%

Consensus EPS estimates fall by 50%

Recent updates

Paysign: Expect Rapid Growth In Its Pharma Business

Independent Director exercised options to buy US$85k worth of stock.

Consensus EPS estimates increase by 33%

Price target increased by 8.9% to US$6.13

First quarter 2024 earnings released: EPS: US$0.006 (vs US$0.003 loss in 1Q 2023)

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

Consensus EPS estimates fall by 30%, revenue upgraded

PaySign, Inc., Annual General Meeting, May 03, 2024

Here's Why We Think PaySign (NASDAQ:PAYS) Is Well Worth Watching

Price target increased by 14% to US$5.25

Full year 2023 earnings: EPS and revenues exceed analyst expectations

CFO & Treasurer exercised options and sold US$79k worth of stock

PaySign, Inc. Announces Executive Changes

Revenues Tell The Story For PaySign, Inc. (NASDAQ:PAYS)

Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of the Common Stock of Paysign, Inc

Consensus EPS estimates increase by 25%

New major risk - Earnings quality

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Market cap size

Consensus EPS estimates fall by 50%

PaySign, Inc. Reaffirms Earnings Guidance for the Year 2023

Second quarter 2023 earnings released: US$0.002 loss per share (vs US$0.004 loss in 2Q 2022)

Co-Founder exercised options and sold US$71k worth of stock

New minor risk - Market cap size

Consensus EPS estimates fall by 20%

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.006 loss in 1Q 2022)

Consensus EPS estimates increase by 36%

Price target increased by 13% to US$4.31

CFO & Treasurer recently sold US$101k worth of stock

PaySign, Inc. Elects Jeffrey B. Newman to Its Board of Directors

Consensus EPS estimates have been upgraded.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

PaySign, Inc. Provides Earnings Guidance for the Fiscal Year 2022

General Counsel exercised options to buy US$54k worth of stock.

The Recovery At PaySign Has Legs

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to US$3.75

PaySign, Inc. Provides Revenue Guidance for the Third and Fourth Quarter of 2022

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

PaySign, Inc. Provides Earnings Guidance for the Full Year of 2022

PaySign, Inc. Provides Earnings Guidance for the Full Year of 2022

Price target decreased to US$3.44

Insufficient new directors

Price target decreased to US$3.44

Insufficient new directors

PaySign: A 'Backdoor' $2 Stagflation Play

Paysign: My Top Rebound Pick For 2022

Paysign: The Plasma Toll Booth

PaySign's Post-Pandemic Payoff

PaySign, Inc.(NasdaqCM:PAYS) dropped from Russell 2000 Defensive Index

PaySign, Inc. Provides Earnings Guidance for the Full Year 2021

Paysign, Inc. Announces Retirement of Joan M. Herman, as Chief Operating Officer

Why PaySign Is A Very Good Company

PaySign: Long-Term Story Still Intact

PaySign, Inc. and ImmunoTek Bio Centers LLC Collaborate in Support of COVID-19 Convalescent Plasma Collection

PaySign, Inc. announced delayed 10-Q filing

Paysign reports Q3 results

PaySign, Inc. to Report Q3, 2020 Results on Nov 17, 2020

PaySign, Inc. to Report Q2, 2020 Results on Aug 13, 2020

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘